This article has been retracted at the request of the Editorin- Chief, the International Society of Oncology and BioMarkers (ISOBM) and the Publisher per the Committee on Publication Ethics guidelines. The article shows evidence of irregularities in authorship, there is strong reason to believe that the peer review process was compromised and the article is showing similarities with the following article which was submitted within a close timeframe: Seyad Alireza Bassampour, Reza Abdi, Reza Bahador, Mohammadreza Shakeri, Ali Torkaman, Emad Yahaghi, Afshin Taheriazam, Downregulation of miR-133b/miR-503 acts as efficient prognostic and diagnostic factors in patients with osteosarcoma and these predictor biomarkers are correlated with overall ...
Tian K, Sun D, Chen M, et al. Onco Targets Ther. 2020;13:1277–1287. The Editor and Publisher o...
Yang F, Zhang C, Xu C, Fu F, Han D, Li H. Onco Targets Ther. 2019;12:4415–4426. The Editor and...
Jiao D, Liu Y, Tian Z. Onco Targets Ther. 2019;12:6947–6959. The Editor and Publisher of OncoT...
The Editors-in-Chief and Publisher have retracted this article 1 because the scientific integrity of...
The Editor-in-Chief and Publisher have retracted this article 1 because the scientific integrity of ...
The Editor-in-Chief and Publisher have retracted this article 1 because the scientific integrity of ...
Yin R, Liu J, Zhao D, Wang F. Onco Targets Ther. 2020;13:2261–2274. The Editor and Publisher o...
Li B, Zhao J, Zhao Q, et al. Onco Targets Ther. 2019;12:9795–9807. The Editor and Publisher of...
A Retraction to this paper has been published and can be accessed via a link at the top of the paper
Li Y, Zeng C, Tu M, et al. Onco Targets Ther. 2016;9:3101–3111. The Editor and Publisher of On...
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/1...
This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevi...
Lv Z, Ma J, Wang J, Lu J. Onco Targets Ther. 2019;12:8501–8513. The Editor and Publisher of On...
Zhang W, Liao K, Liu D. Cancer Manag Res. 2020;12:8137–8147. The Editor and Publisher of Canc...
Zhang L, Li C, Cao L, et al. Cancer Manag Res. 2019;11:2769–2781. The Editor and Publisher of ...
Tian K, Sun D, Chen M, et al. Onco Targets Ther. 2020;13:1277–1287. The Editor and Publisher o...
Yang F, Zhang C, Xu C, Fu F, Han D, Li H. Onco Targets Ther. 2019;12:4415–4426. The Editor and...
Jiao D, Liu Y, Tian Z. Onco Targets Ther. 2019;12:6947–6959. The Editor and Publisher of OncoT...
The Editors-in-Chief and Publisher have retracted this article 1 because the scientific integrity of...
The Editor-in-Chief and Publisher have retracted this article 1 because the scientific integrity of ...
The Editor-in-Chief and Publisher have retracted this article 1 because the scientific integrity of ...
Yin R, Liu J, Zhao D, Wang F. Onco Targets Ther. 2020;13:2261–2274. The Editor and Publisher o...
Li B, Zhao J, Zhao Q, et al. Onco Targets Ther. 2019;12:9795–9807. The Editor and Publisher of...
A Retraction to this paper has been published and can be accessed via a link at the top of the paper
Li Y, Zeng C, Tu M, et al. Onco Targets Ther. 2016;9:3101–3111. The Editor and Publisher of On...
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/1...
This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevi...
Lv Z, Ma J, Wang J, Lu J. Onco Targets Ther. 2019;12:8501–8513. The Editor and Publisher of On...
Zhang W, Liao K, Liu D. Cancer Manag Res. 2020;12:8137–8147. The Editor and Publisher of Canc...
Zhang L, Li C, Cao L, et al. Cancer Manag Res. 2019;11:2769–2781. The Editor and Publisher of ...
Tian K, Sun D, Chen M, et al. Onco Targets Ther. 2020;13:1277–1287. The Editor and Publisher o...
Yang F, Zhang C, Xu C, Fu F, Han D, Li H. Onco Targets Ther. 2019;12:4415–4426. The Editor and...
Jiao D, Liu Y, Tian Z. Onco Targets Ther. 2019;12:6947–6959. The Editor and Publisher of OncoT...